News & Events
Find out more about dates & events, the progress of our vaccine research and all the other interesting news on the topic.
News
12 November 2024
Verovaccines erhält BSFZ-Siegel und Forschungszulage
Verovaccines wurde mit dem BSFZ-Siegel ausgezeichnet, was die Vergabe der Forschungszulage ermöglicht. Diese finanzielle Unterstützung richtet sich an Unternehmen, die in Forschung und Entwicklung investieren. Mit der Förderung kann Verovaccines seine Aktivitäten in der Impfstoffentwicklung weiter intensivieren und innovative, zukunftsweisende Lösungen zur Bekämpfung von Infektionskrankheiten entwickeln.
15 October 2024
EU fördert Mitarbeiterweiterbildung in Schlüsselkompetenzen
Die Europäische Union hat die Weiterbildung der Mitarbeitenden bei Verovaccines durch den Europäischen Sozialfond (ESF) gefördert.
In mehreren Veranstaltungen wurde das ganze Team geschult um Schlüsselkompetenzen wie Zeitmanagement, Organisation und Teamkommunikation zu steigern. Darüber hinaus konnte das Leitungspersonal gezielt Fähigkeiten in der Personalführung verbessern. Diese Aktivitäten ermöglichen es Verovaccines, die Effizienz zu steigern und Innovationen schneller umzusetzen, und betont die Bedeutung der Mitarbeiterentwicklung für Wettbewerbsfähigkeit und Innovationskraft.
11 October 2024
Tierimpfstoff-Entwickler erörtert mit EU-Parlamentarierin Auswirkungen von Seuchenfällen auf den EU-Binnenmarkt
- Verovaccines diskutiert mit EU-Parlamentarierin Anna Cavazzini die gegenwärtige Bedrohungslage
durch Tierseuchenausbrüche für den europäischen Binnenmarkt - Das Unternehmen kann schnelle und wirksame Impfstofflösungen für Seuchenausbrüche
bereitstellen - Diskussion von Verbesserungen des EU-Programms zum Schutz vor Ausbrüchen
8 October 2024
Rapid emergency vaccine development in months
- Verovaccines develops the first recombinant subunit vaccine against the current bluetongue virus -3 (BTV-3) outbreak that impacts sheep and cattle in Europe
- Using a new vaccine construction technology, first vaccines were generated within weeks. Within 9 months, 90% of the dossier was completed
- The company uses its new capabilities for fast emergency responses and cost-efficient classical vaccine development in animal health
11 July 2023
Verovaccines enters company growth phase
- Vaccine developer completes the validation of its vaccine and manufacturing platforms.
- Company to focus now on development to bring new vaccines to market quickly. Another swine vaccine enters pipeline.
14 December 2022
EU fördert Mitarbeiterweiterbildung
Auch im Jahr 2022 wurde die Weiterentwicklung der VEROVACCiNES GmbH vorangetrieben. Mit Hilfe einer Förderung der beruflichen Weiterbildung von Beschäftigten in Unternehmen aus Mitteln des Europäischen Sozialfonds (ESF) konnten mehrere Mitarbeiter in den Bereichen „Good Manufacturing Practice“ und „Good Laboratory Practice“ weitergebildet werden. Mit diesen Maßnahmen wird das Qualitätsniveau weiter gehoben.
12 October 2022
Verovaccines paves way for manufacturing its vaccines
- Verovaccines upscales manufacturing processes of its yeast-based vaccines to industrial scale
- This is an important milestone on the road to commercialization of this novel vaccine class
24 March 2022
VEROVACCiNES is now using a twin fermenter – many thanks to INFORS HT
The new twin-fermenter will enable us to boost the number of fermentation runs in order to
- speed up optimization of manufacturing (upstream processing)
- generate quality data for our K. lactis yeast system (run-to-run consistency: biomass yield, antigen content, process reliability…)
- produce vaccine material for efficacy and safety trials under highly controlled conditions
Events
10 – 12 February 2025
2025, February 10 – 12, Animal Health Innovation, London
We will participate in the Animal Health Innovation in London, showcasing its innovative vaccine research. The event offers an opportunity to connect with industry leaders and explore the latest trends in animal health.
16 July 2024
2024, OCTOBER 08 – 10, CPHI, MILAN, ITALY
Getting closer to manufacturing, CPHI is an important conference to go. We are active in the animal health field and are looking for compatible solutions and providers. We are looking forward to meet you in Milan!
19 July 2024
2024, AUGUST 26 – 27 ANIMAL HEALTH SUMMIT, KANSAS CITY, USA
We will be there! From 26-27 August 2024 in Kansas City, USA. We are expanding our activities to the USA and are looking for partners and investors. We’d be happy to meet you!
22 April 2024
2024, JUNE 04. – 07. IPVS & ESPHM, LEIPZIG, GERMANY
We will attend the IPVS and ESPHM Congress in Leipzig. Meeting new people, expanding our network and creating new interactions will be our focus. Dr Hanjo Hennemann will give a talk about „An innovative subunit vaccine platform for livestock, validated in pigs and other species“. We are looking forward to see you!
12 January 2024
2024, March 04. – 06. Animal Health Innovation Europe, London
It is THE summit for animal health in Europe, and once again we cannot miss it.
We look forward to interesting discussions in March! See you there.
10 January 2024
2024, February 06. – 08. DIAH Conference, Gent
As developers with new innovations, our aim is to exchange ideas with other players in this field and expand our knowledge. For this reason, we will be attending the conference in Belgium for the first time in 2024. We are excited.
03 January 2024
2024, January 18. – 20. LEIPZIG VETERINARY CONGRESS 2024, Germany
The Leipzig Veterinary Congress is the largest continuing education event for veterinarians in the German-speaking world and one of the leading specialist platforms in Europe. It is clear that our practising vets can be found at this congress on these days.
28 November 2023
2023, December 12. – 14. BioFit Marseille
Did you know that Marseille is one of the best innovation centres for biotechnology in Europe?
That’s why BioFit takes place in this beautiful port city this year, where Dr Hanjo Hennemann will also be present as a speaker.